Safety evaluation of a short-term infusion of ramucirumab for GI tract cancer patients

ABSTRACT: Interventions: To administer ramucirumab in a short period of time Primary outcome(s): Incidence of infusion related reaction (any grade) at the first short-term infusion Study Design: Single arm Non-randomized

DISEASE(S): Gastric And Colorectal Cancer

PROVIDER: 2644505 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR